Limba
Romanian
Link-uri
  • Comparati ()
  • Despre noi
  • Contactati-ne
  • Creati cont
|
Comutare în navigare
Cautare avansata

SUNĂ ACUM

+40 (264) 523 281

Cart 0 Cos de cumparaturi
Menu
Account
Setari
Limba
Romanian
main product photo
Se încarca...
R3011, Quick-SARS-CoV-2 rRT-PCR Kit (100 rxns)

R3011, Quick-SARS-CoV-2 rRT-PCR Kit (100 rxns)

R3011-1K, Quick SARS-CoV-2 rRT-PCR Kit (1000 rxns)

R3011-1K, Quick SARS-CoV-2 rRT-PCR Kit (1000 rxns)

R3011-10K, Quick SARS-CoV-2 rRT-PCR Kit (10,000 rxns)

920.708,95 RON

The Quick SARS-CoV-2 rRT-PCR Kit is a real-time reverse transcription PCR (rRT-PCR) test for the qualitative detection of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the coronavirus disease (COVID-19).

The Quick SARS-CoV-2 rRT-PCR Kit detects N1, N2, and N3 regions of the viral nucleocapsid (N) gene and a host-specific target region (human RNase P gene) to assess sample quality. The kit also includes CV Positive Control that enable assay performance monitoring, and a No-Template Control to confirm the absence of contamination in the reagents.

The Quick SARS-CoV-2 rRT-PCR Kit can be used on purified RNA samples isolated from upper respiratory and lower respiratory systems.

The Quick SARS-CoV-2 rRT-PCR Kit has High Sensitivity, with a Limit of Detection as low as 15 viral genome equivalent copies per reaction, a fast turnaround time of less than 1.5 hours, and a simple workflow in which RNA is simply added to the Quick SARS-CoV-2 rRT-PCR Kit reagents and directly analyzed.

Due to its simplicity, set-up up can be performed in an automation and it is compatible with high-throughput platforms. The kit is compatible with multiple Real-Time PCR instruments and technical support is available for all steps of the setup process and data interpretation.

SKU
ZR_R3011-10K
Adaugati pentru comparare
HIGHLIGHTS
  • Approved for emergency use authorization (EUA) by the U.S. Food and Drug Administration and CE-IVD certified.
  • High Sensitivity: Ranked among the top three most sensitive EUA tests by the FDA, with a Limit of Detection as low as 250 GEC/ml (15 GEC/reaction).
  • Specific: Detection of SARS-CoV-2 and Emerging Strains (including Omicron)
  • Rapid & Easy Setup: Ready-to-use Master Mix, just add sample.
  • Compatible with Automated and High-Throughput workflows.
DESCRIPTION

 

The Quick SARS-CoV-2 rRT-PCR Kit is a real-time reverse transcription PCR (rRT-PCR) test for the qualitative detection of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the coronavirus disease (COVID-19).

The Quick SARS-CoV-2 rRT-PCR Kit detects N1, N2, and N3 regions of the viral nucleocapsid (N) gene and a host-specific target region (human RNase P gene) to assess sample quality. The kit also includes CV Positive Control that enable assay performance monitoring, and a No-Template Control to confirm the absence of contamination in the reagents.

The Quick SARS-CoV-2 rRT-PCR Kit can be used on purified RNA samples isolated from upper respiratory and lower respiratory systems.

The Quick SARS-CoV-2 rRT-PCR Kit has High Sensitivity, with a Limit of Detection as low as 15 viral genome equivalent copies per reaction, a fast turnaround time of less than 1.5 hours, and a simple workflow in which RNA is simply added to the Quick SARS-CoV-2 rRT-PCR Kit reagents and directly analyzed.

Due to its simplicity, set-up up can be performed in an automation and it is compatible with high-throughput platforms. The kit is compatible with multiple Real-Time PCR instruments and technical support is available for all steps of the setup process and data interpretation.

Learn More

In the United States:

-This test has not been FDA cleared or approved;
-This test has been authorized by FDA under an EUA for use by authrized laboratories;
-This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and
-This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the authorization is terminated or revoked sooner

Qualitative assay for use on the Bio-Rad CFX96 Real-Time PCR Detection System. For use under the FDA Emergency Use Authorization (EUA) only. For in vitro diagnostic use.

 

TECHNICAL SPECIFICATIONS
Compatibility Compatible with automated and high-throughput workflows.
Equipment Required Real-Time PCR Instruments capable of detecting HEX™ and Quasar® 670/Cy5 fluorophores.
Input Quality Purified RNA free of enzymatic inhibitors.
Processing Time ≤ 1.5 hours from set up to results.
Reagents Complete and ready to use master mixes.
Registration Status FDA-Emergency Use Authorization
CE-IVD certified
Sample Input Material Purified RNA samples isolated from upper respiratory and lower respiratory systems.
Supplemental Info

Mai multe informatii

Mai multe informatii
Price 773.705,00 RON (preturile sunt fara TVA)
Description
HIGHLIGHTS
  • Approved for emergency use authorization (EUA) by the U.S. Food and Drug Administration and CE-IVD certified.
  • High Sensitivity: Ranked among the top three most sensitive EUA tests by the FDA, with a Limit of Detection as low as 250 GEC/ml (15 GEC/reaction).
  • Specific: Detection of SARS-CoV-2 and Emerging Strains (including Omicron)
  • Rapid & Easy Setup: Ready-to-use Master Mix, just add sample.
  • Compatible with Automated and High-Throughput workflows.
DESCRIPTION

 

The Quick SARS-CoV-2 rRT-PCR Kit is a real-time reverse transcription PCR (rRT-PCR) test for the qualitative detection of RNA from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which is responsible for the coronavirus disease (COVID-19).

The Quick SARS-CoV-2 rRT-PCR Kit detects N1, N2, and N3 regions of the viral nucleocapsid (N) gene and a host-specific target region (human RNase P gene) to assess sample quality. The kit also includes CV Positive Control that enable assay performance monitoring, and a No-Template Control to confirm the absence of contamination in the reagents.

The Quick SARS-CoV-2 rRT-PCR Kit can be used on purified RNA samples isolated from upper respiratory and lower respiratory systems.

The Quick SARS-CoV-2 rRT-PCR Kit has High Sensitivity, with a Limit of Detection as low as 15 viral genome equivalent copies per reaction, a fast turnaround time of less than 1.5 hours, and a simple workflow in which RNA is simply added to the Quick SARS-CoV-2 rRT-PCR Kit reagents and directly analyzed.

Due to its simplicity, set-up up can be performed in an automation and it is compatible with high-throughput platforms. The kit is compatible with multiple Real-Time PCR instruments and technical support is available for all steps of the setup process and data interpretation.

Learn More

In the United States:

-This test has not been FDA cleared or approved;
-This test has been authorized by FDA under an EUA for use by authrized laboratories;
-This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; and
-This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the authorization is terminated or revoked sooner

Qualitative assay for use on the Bio-Rad CFX96 Real-Time PCR Detection System. For use under the FDA Emergency Use Authorization (EUA) only. For in vitro diagnostic use.

 

TECHNICAL SPECIFICATIONS
Compatibility Compatible with automated and high-throughput workflows.
Equipment Required Real-Time PCR Instruments capable of detecting HEX™ and Quasar® 670/Cy5 fluorophores.
Input Quality Purified RNA free of enzymatic inhibitors.
Processing Time ≤ 1.5 hours from set up to results.
Reagents Complete and ready to use master mixes.
Registration Status FDA-Emergency Use Authorization
CE-IVD certified
Sample Input Material Purified RNA samples isolated from upper respiratory and lower respiratory systems.
Supplemental Info